Oral antibiotics for bloodstream infection trial
Treatments studied
Part of Infections clinical trials.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and currently in the hospital.
- A blood test must have found a specific type of bacteria called Gram-negative in your bloodstream.
- You must be able to take antibiotics by mouth and not need medications to raise your blood pressure.
- Your infection should be treatable with oral antibiotics, and doctors should expect treatment to last 14 days or less.
- You should not have a brain or spinal cord infection, very low white blood cell count, or be in hospice care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
This trial tests different ways to treat infections in the blood caused by Gram-negative bacteria. It looks at whether reducing antibiotics, switching to pills, or managing central lines improves outcomes while keeping you safe.
This trial tests whether children with a bloodstream infection can safely switch from intravenous (IV) antibiotics to oral (by mouth) antibiotics earlier, after showing improvement. It aims to reduce hospital stays and make treatment easier for children.
This trial tests whether switching from IV antibiotics to oral antibiotics after 3–7 days is safe and effective for people with uncomplicated Staphylococcus aureus bloodstream infections. It may help you avoid a longer hospital stay and reduce IV-related complications.
This study tests a careful antibiotic-use program for patients with a bloodstream infection caused by a group of bacteria called Enterobacterales. The goal is to use the right antibiotics for the right amount of time. It may help you get better treatment with fewer side effects.
This trial compares starting antibiotics through a vein (IV) to taking them by mouth for common infections like pneumonia, urinary tract infections, or skin infections (cellulitis). The goal is to see if oral antibiotics work just as well without the need for an IV line.
Hear when a new Gram-negative Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.